TRK-IN-25

• UNSPSC Description:

  TRK-IN-25 (compound 16) is a Trk inhibitor with antiproliferative activity against cancer cells. TRK-IN-25 can be used in cancer research[1].

• Target Antigen:

  Trk Receptor

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling;Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/trk-in-25.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=C(N(C2=CC=C(C=C2)F)C1=O)OC(C)C)NC3=CC=C(C(F)=C3)OC4=CC5=C(C=C4C6=CNN=C6)N(C)N=C5

• Molecular Weight:

  596.58

• References & Citations:

  [1]Boyu Zhong, et al. Trk inhibitor as anti-cancer drug. Patent WO2020048455A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2412309-60-3